AI Visibility Scorecard
MYFEMBREE® (relugolix, estradiol, and norethindrone acetate) Patient Website
myfembree.com · Healthcare
Borderline visible. AI bots can crawl MYFEMBREE® (relugolix, estradiol, and norethindrone acetate) Patient Website, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 7 times
Meta AI · Claude
#31,323 of 924,420 in Healthcare for AI visibility
4
5
AEO Visibility
iBorderline · 4.6/10
60
Muse Index Score
iAI agent readiness
Transactable · 60/100
0
AI Adoption
iNone detected · 0/100
About MYFEMBREE® (relugolix, estradiol, and norethindrone acetate) Patient Website
from our crawl and measurement
MYFEMBREE® (relugolix, estradiol, and norethindrone acetate) Patient Website, based in Marlborough, Massachusetts, describes itself simply: "Choose a condition to discover symptom relief with Myfembree." To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 4.6 out of 10.
Our crawl found structured data on the page (MedicalWebPage), a sitemap and a readable heading structure. It is missing an llms.txt file.
AI crawlers have visited 2 times in our tracking, including ClaudeBot (Anthropic) and Meta AI.
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Fair
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.6/10, MYFEMBREE® (relugolix, estradiol, and norethindrone acetate) Patient Website is crawlable but under-signaled - fixable, and the signals above are where to start.
Frequently Asked Questions
Already prescribed Myfembree?
Great! You may already be on the path to relief. Learn how to correctly take Myfembree. HOW TO TAKE MYFEMBREE
Is this your brand?
The exact fixes for MYFEMBREE® (relugolix, estradiol, and norethindrone acetate) Patient Website
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for MYFEMBREE® (relugolix, estradiol, and norethindrone acetate) Patient Website.
Source & Attribution
Scored by Engagemii on August 8, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/myfembree
Cite this score: Engagemii (2026). "AEO Score for MYFEMBREE® (relugolix, estradiol, and norethindrone acetate) Patient Website." Retrieved from https://engagemii.com/aeo/brands/myfembree
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform